MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers.

Sadeghian, Dorsay; Saffar, Hana; Mahdavi Sharif, Pouya; Soleimani, Vahid; Jahanbin, Behnaz

Sadeghian, Dorsay; Saffar, Hana; Mahdavi Sharif, Pouya; Soleimani, Vahid; Jahanbin, Behnaz.

Afiliación

Sadeghian D; Cancer Institute, Pathology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Saffar H; Present address: Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN, USA.
Mahdavi Sharif P; Cancer Institute, Pathology Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Soleimani V; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Jahanbin B; Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Diagn Pathol ; 17(1): 24, 2022 Feb 06.

Article en En | MEDLINE | ID: mdl-35125121

Asunto(s)

Neoplasias de la Mama; Biomarcadores de Tumor/metabolismo; Neoplasias de la Mama/genética; Estudios Transversales; Femenino; Humanos; Antígeno Ki-67/metabolismo; Componente 6 del Complejo de Mantenimiento de Minicromosoma; Pronóstico; Receptor ErbB-2/metabolismo; Receptores de Progesterona/metabolismo; Estudios Retrospectivos

Palabras clave

Biomarkers; Breast cancer; Diagnostic; Ki67; Luminal B; Luminal a; MCM6

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Diagn Pathol Asunto de la revista: PATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google